Analyses estimating program costs collected on a subsample of facilities are subject to statistical uncertainty, often quantified via standard errors and/or 95% confidence intervals. This recent publication elaborates methods to reduce statistical uncertainty.
Local engagement and empowerment have been essential for the DOVE study to develop cost of illness estimates and apply them to policymaking and program planning in Uganda. Here are some ideas and tools you can use...
Three modules were published from TVEE's vaccine economics curriculum, available to the public for free, on the JHSPH OpenCourseWare (OCW). Anybody can now download lecture slides, syllabi and exercises from this curriculum. Read more here
Recent study estimate cost drivers and unit costs of Immunization and other essential services package in Bangladesh. Supplemented with epidemiological and demographical data, this information could be used to help with policy and decision making. Read more here
Benin’s commitment to immunization continues to grow, though sustainability of financing remains a concern. Comparisons with neighboring countries reveal potential lessons for Benin, around efficiency and sustainability. [Eng], [Fr]
A new analysis of health and household economic impact of 10 vaccine antigens across income quintiles for 41 low- and middle-income countries indicates predominant benefit in lowest quintiles, improving health equity. Read more here.
A new publication explains main challenges that countries and donors face in achieving smooth transitions, points to the key strategies and tools that should be used and outlines a recommended agenda for priority research in this area. Read more here.
The workshops series in Jaipur, Karachi, and Kampala focuses on capacity building in applied vaccine economics and financing. Read more here
In the October 2017 Newsletter Issue, Dr. Brenzel thanks and welcomes the members of the Immunization Economics Community of Practice. Read her welcome letter here.
Dr Orin Levine: "Virtually every child in the world can access a Coca-Cola, yet globally, one in every seven children is still excluded from vaccines. In Africa, one in five go unvaccinated." Read more here
Using a unique pooled dataset of 316 health facilities in six countries, EPIC project analyses describe differences in unit cost estimates assocated with service volume, delivery methods, immunization coverage, staff training, seniority, and site location. Access datasets and paper here.
A two-day Methods and Case Studies workshop in Boston seek to develop reference case guidelines for benefit-cost analysis in global health and development. Discussants include Larry Summers, Sue Goldie, and Dean Jamison. Read more here
Health Policy & Planning podcast discusses the importance in understanding detailed cost structure, its relationship with efficiency, and implications for health policy and future planning in immunization programs. Listen to podcast here.
Research helps stakeholders in Bangladesh and other countries make more informed decisions about the true economic burden of childhood diseases and better evaluate investments in vaccines. Read more here
Research teams & policymakers from Indonesia, Tanzania & Vietnam met in Hanoi to discuss costing study designs & cross cutting methods issues for the ICAN project - working towards sustainable immunization financing. Read more here
Health Policy and Planning blogpost examines how detailed understanding of the cost structure of immunization programs can inform policy. Read more here.
Focused on capacity building in applied vaccine economics, cost-effectiveness and finance, TVEE targets audience who are current decision-makers in EPI programs, NiTAGs and partners in GAVI eligible countries. Watch video here
The Value of Vaccination Research Network (VoVRN) is pleased to announce the initiation of a grant-making cycle to fund research on the broader social and economic impacts of vaccination (BSEIV) due Aug 4 2017. See instructions here.
Gavi committed to monitoring externalities of it activities in countries, and on manufacturers and partners. To do so, we are asking the public to help identify externalities of market shaping and how to monitor them. See more here
Submit new information [here]